Skip to content

A randomized controlled study of the medium - and long-term efficacy of gabapentin in patients with alcohol dependence

A randomized controlled study of the medium - and long-term efficacy of gabapentin in patients with alcohol dependence

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036214
Enrollment
Unknown
Registered
2020-08-21
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol dependence

Interventions

Gabapentin Group:Taking gabapentin
SSRIs Group:Taking SSRIs
Valproate Group:Taking Valproate

Sponsors

The Second Affiliated Hospital of Xinxiang Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Subjects who meet the diagnostic criteria of alcohol dependence in ICD-10 and dsm-5; 2. Male, aged 20-60, Han nationality, junior high school or above.

Exclusion criteria

Exclusion criteria: 1. Patients with previous history of gabapentin allergy or allergic reaction during treatment; 2. Patients with other major body diseases or severe liver and kidney injury; 3. Patients with history of other psychoactive substance abuse (except tobacco); 4. Patients with other psychiatric diseases and symptoms; 5. Patients with epileptic seizure history; 6. Subjects with history of craniocerebral trauma and coma.

Design outcomes

Primary

MeasureTime frame
Clinic Institute Alcohol Withdrawal Syndrome Scale, CIWA-Ar;Penn Alcohol Craving Scale, PACS;Hamilton Anxiety Scale, HAMA;Hamilton Depression Scale, HAMD;Pittsburgh Sleep Quality Index, PSQI;Epworth Sleepiness Score, ESS;Mini Mental State Examination, MMSE;Trail Making Test B, TMT-B;Digital Span Test, DST;Verbal Fluency Test, VFT;Hopkins Verbol Learning Test-Revised, HVLT-R;Event-Related Potential, ERP ;

Countries

China

Contacts

Public ContactWang Chuansheng

The Second Affiliated Hospital of Xinxiang Medical University

chuansonwang@126.com+86 18537339716

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026